The chemical substance known as "11H,17H-1,18-Etheno-5,9:12,16-dimethenooxacycloheptadecino[8,7-c]pyridine-3,13-dicarbonitrile, 17-amino-17-(1-methyl-1H-imidazol-5-yl)-, (17S)-" with CAS number 2939824-30-1 is a complex organic compound characterized by its unique bicyclic structure, which incorporates both pyridine and imidazole moieties. This compound features multiple functional groups, including dicarbonitrile and amino groups, contributing to its potential reactivity and biological activity. The presence of etheno and metheno groups suggests that it may participate in various chemical reactions, including cycloadditions or polymerizations. Its stereochemistry, indicated by the (17S) designation, implies specific spatial arrangements that could influence its interactions with biological targets. Such compounds are often of interest in medicinal chemistry due to their potential pharmacological properties. However, detailed studies would be necessary to elucidate its specific characteristics, including solubility, stability, and biological activity, as well as any potential applications in drug development or other fields.

11H,17H-1,18-Etheno-5,9:12,16-dimethenooxacycloheptadecino[8,7-c]pyridine-3,13-dicarbonitrile, 17-amino-17-(1-methyl-1H-imidazol-5-yl)-, (17S)-

2939824-30-1: The chemical substance known as "11H,17H-1,18-Etheno-5,9:12,16-dimethenooxacycloheptadecino[8,7-c]pyridine-3,13-dicarbonitrile, 17-amino-17-(1-methyl-1H-imidazol-5-yl)-, (17S)-" with CAS number 2939824-30-1 is a complex organic compound characterized by its unique bicyclic structure, which incorporates both pyridine and imidazole moieties. This compound features multiple functional groups, including dicarbonitrile and amino groups, contributing to its potential reactivity and biological activity. The presence of etheno and metheno groups suggests that it may participate in various chemical reactions, including cycloadditions or polymerizations. Its stereochemistry, indicated by the (17S) designation, implies specific spatial arrangements that could influence its interactions with biological targets. Such compounds are often of interest in medicinal chemistry due to their potential pharmacological properties. However, detailed studies would be necessary to elucidate its specific characteristics, including solubility, stability, and biological activity, as well as any potential applications in drug development or other fields.

Darlifarnib (Compound (S)-058) is an inhibitor of farnesyl transferase and geranylgeranyltransferase, with IC50 values of ≤ 10 nM and > 1000 nM, respectively. It exhibits high metabolic stability in human and mouse liver microsomes, with a half-life of over 100 minutes.

CAS 2939824-30-1

11H,17H-1,18-Etheno-5,9:12,16-dimethenooxacycloheptadecino[8,7-c]pyridine-3,13-dicarbonitrile, 17-amino-17-(1-methyl-1H-imidazol-5-yl)-, (17S)-

Darlifarnib

Ref: TM-T206317